Collagen type XI α1 facilitates head and neck squamous cell cancer growth and invasion

British Journal of Cancer

Volumn 109, Issue 12, 2013, Pages 3049-3056

  Sok, J C ^a,d   Lee, J A ^a   Dasari, S ^a   Joyce, S ^a   Contrucci, S C ^a   Egloff, A M ^a   Trevelline, B K ^a   Joshi, R ^a   Kumari, N ^a   Grandis, J R ^a,b   Thomas, S M ^c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^d LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 11; COLLAGEN TYPE 11 ALPHA1; COMPLEMENTARY DNA; MESSENGER RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER GROWTH; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBROBLAST; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR INVASION; TUMOR MICROENVIRONMENT;

ADULT; AGED; AGED, 80 AND OVER; CARCINOGENESIS; CARCINOMA, SQUAMOUS CELL; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL MOVEMENT; COLLAGEN TYPE XI; DISEASE PROGRESSION; FEMALE; GENE KNOCKDOWN TECHNIQUES; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROTEIN ISOFORMS; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 84890430190     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.624     Document Type: Article

References (37)

1. Anastassiou D, Rumjantseva V, Cheng W, Huang J, Canoll PD, Yamashiro DJ, Kandel JJ (2011) Human cancer cells express Slug-based epithelialmesenchymal transition gene expression signature obtained in vivo. BMC Cancer 11: 529.
2. Badea L, Herlea V, Dima SO, Dumitrascu T, Popescu I (2008) Combined gene expression analysis of whole-tissue and microdissected pancreatic ductal adenocarcinoma identifies genes specifically overexpressed in tumor epithelia. Hepatogastroenterology 55(88): 2016-2027.
3. Bedi GC, Westra WH, Gabrielson E, Koch W, Sidransky D (1996) Multiple head and neck tumors: evidence for a common clonal origin. Cancer Res 56(11): 2484-2487.
4. Blaschke RJ, Howlett AR, Desprez PY, Petersen OW, Bissell MJ (1994) Cell differentiation by extracellular matrix components. Methods Enzymol 245: 535-556.
5. Blaschke UK, Eikenberry EF, Hulmes DJ, Galla HJ, Bruckner P (2000) Collagen XI nucleates self-assembly and limits lateral growth of cartilage fibrils. J Biol Chem 275(14): 10370-10378.
6. Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, Jones CU, Sur R, Raben D, Jassem J, Ove R, Kies MS, Baselga J, Youssoufian H, Amellal N, Rowinsky EK, Ang KK (2006) Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck. New Engl J Med 354(6): 567-578.
7. Cheng WY, Ou Yang TH, Anastassiou D (2013) Biomolecular events in cancer revealed by attractor metagenes. PLoS Comput Biol 9(2): e1002920.
8. Chong I-W, Chang M-Y, Chang H-C, Yu Y-P, Sheu C-C, Tsai J-R, Hung J-Y, Chou S-H, Tsai M-S, Hwang J-J, Lin S-R (2006) Great potential of a panel of multiple hMTH1, SPD, ITGA11 and COL11A1 markers for diagnosis of patients with non-small cell lung cancer. Oncol Rep 16(5): 981-988.
9. Cognetti DM, Weber RS, Lai SY (2008) Head and neck cancer-an evolving treatment paradigm. Cancer 113(7): 1911-1932.
10. De Wever O, Mareel M (2003) Role of tissue stroma in cancer cell invasion. J Pathol 200(4): 429-447.
11. Ellsworth RE, Seebach J, Field LA, Heckman C, Kane J, Hooke JA, Love B, Shriver CD (2009) A gene expression signature that defines breast cancer metastases. Clin Exp Metastasis 26(3): 205-213.
12. Eyre DR, Weis MA, Wu JJ (2006) Articular cartilage collagen: an irreplaceable framework? Eur Cell Mater 12: 57-63.
13. Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin D. GLOBOCAN (2008) Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. International Agency for Research on Cancer; 2010: Lyon, France. Available from http://globocan.iarc.fr.
14. Fischer H, Salahshor S, Stenling R, Bjork J, Lindmark G, Iselius L, Rubio C, Lindblom A (2001a) COL11A1 in FAP polyps and in sporadic colorectal tumors. BMC cancer 1: 17.
15. Fischer H, Stenling R, Rubio C, Lindblom A (2001b) Colorectal carcinogenesis is associated with stromal expression of COL11A1 and COL5A2. Carcinogenesis 22(6): 875-878.
16. Grenman R, Carey TE, McClatchey KD, Wagner JG, Pekkola-Heino K, Schwartz DR, Wolf GT, Lacivita LP, Ho L, Baker SR (1991) In vitro radiation resistance among cell lines established from patients with squamous cell carcinoma of the head and neck. Cancer 67(11): 2741-2747.
17. Halsted KC, Bowen KB, Bond L, Luman SE, Jorcyk CL, Fyffe WE, Kronz JD, Oxford JT (2008) Collagen alpha1(XI) in normal and malignant breast tissue. Mod Pathol 21(10): 1246-1254.
18. Hickok JR, Sahni S, Mikhed Y, Bonini MG, Thomas DD (2011) Nitric oxide suppresses tumor cell migration through N-Myc downstream-regulated gene-1 (NDRG1) expression: role of chelatable iron. J Biol Chem 286(48): 41413-41424.
19. Kim H, Watkinson J, Varadan V, Anastassiou D (2010) Multi-cancer computational analysis reveals invasion-associated variant of desmoplastic reaction involving INHBA, THBS2 and COL11A1. BMC Med Genomics 3: 51-62.
20. Krause CJ, Carey TE, Ott RW, Hurbis C, McClatchey KD, Regezi JA (1981) Human squamous cell carcinoma. Establishment and characterization of new permanent cell lines. Arch Otolaryngol 107(11): 703-710.
21. Lansford CGR, Bier H, Somers KD, Kim SY, Whiteside TL, Clayman G, Carey TE (1999) Head and neck cancers. In: Masters JR, Palsson B (eds.) Human cell culture. Vol 2, pp 185-255. Kluwer Academic Publishers: Dordrecht
22. Kluwer Academic Publishers: Dordrecht. Navab R, Strumpf D, Bandarchi B, Zhu CQ, Pintilie M, Ramnarine VR, Ibrahimov E, Radulovich N, Leung L, Barczyk M, Panchal D, To C, Yun JJ, Der S, Shepherd FA, Jurisica I, Tsao MS (2011) Prognostic gene-expression signature of carcinoma-associated fibroblasts in nonsmall cell lung cancer. Proc Natl Acad Sci USA 108(17): 7160-7165.
23. Rangan SR (1972) A new human cell line (FaDu) from a hypopharyngeal carcinoma. Cancer 29(1): 117-121.
24. Rubin Grandis J, Tweardy DJ, Melhem MF (1998) Asynchronous modulation of transforming growth factor alpha and epidermal growth factor receptor protein expression in progression of premalignant lesions to head and neck squamous cell carcinoma. Clinical Cancer Res 4(1): 13-20.
25. Sacks PG, Parnes SM, Gallick GE, Mansouri Z, Lichtner R, Satya-Prakash KL, Pathak S, Parsons DF (1988) Establishment and characterization of two new squamous cell carcinoma cell lines derived from tumors of the head and neck. Cancer Res 48(10): 2858-2866.
26. Schmalbach CE, Chepeha DB, Giordano TJ, Rubin MA, Teknos TN, Bradford CR, Wolf GT, Kuick R, Misek DE, Trask DK, Hanash S (2004) Molecular profiling and the identification of genes associated with metastatic oral cavity/pharynx squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 130(3): 295-302.
27. Scholes AGM, Woolgar JA, Boyle MA, Brown JS, Vaughan ED, Hart CA, Jones AS, Field JK (1998) Synchronous oral carcinomas: independent or common clonal origin? Cancer Res 58(9): 2003-2006.
28. Snyderman CH, Klapan I, Milanovich M, Heo DS, Wagner R, Schwartz D, Johnson JT, Whiteside TL (1994) Comparison of in vivo and in vitro prostaglandin E2 production by squamous cell carcinoma of the head and neck. Otolaryngology Head Neck Surg 111(3 Pt 1): 189-196.
29. Sok JC, Coppelli FM, Thomas SM, Lango MN, Xi S, Hunt JL, Freilino ML, Graner MW, Wikstrand CJ, Bigner DD, Gooding WE, Furnari FB, Grandis JR (2006) Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting. Clin Cancer Res 12(17): 5064-5073.
30. Sok JC, Kuriakose MA, Mahajan VB, Pearlman AN, DeLacure MD, Chen F-A (2003) Tissue-specific gene expression of head and neck squamous cell carcinoma in vivo by complementary DNA microarray analysis. Arch otolaryngol Head Neck Surg 129(7): 760-770.
31. Somers KD, Merrick MA, Lopez ME, Incognito LS, Schechter GL, Casey G (1992) Frequent p53 mutations in head and neck cancer. Cancer Res 52(21): 5997-6000.
32. Spranger J (1998) The type XI collagenopathies. Pediatr Radiol 28(10): 745-750.
33. Stoner GD, Kaighn ME, Reddel RR, Resau JH, Bowman D, Naito Z, Matsukura N, You M, Galati AJ, Harris CC (1991) Establishment and characterization of SV40 T-antigen immortalized human esophageal epithelial cells. Cancer Res 51(1): 365-371.
34. Sturgis EM, Sacks PG, Masui H, Mendelsohn J, Schantz SP (1994) Effects of antiepidermal growth factor receptor antibody 528 on the proliferation and differentiation of head and neck cancer. Otolaryngol Head Neck Surg 111(5): 633-643.
35. Vecchi M, Nuciforo P, Romagnoli S, Confalonieri S, Pellegrini C, Serio G, Quarto M, Capra M, Roviaro GC, Contessini Avesani E, Corsi C, Coggi G, Di Fiore PP, Bosari S (2007) Gene expression analysis of early and advanced gastric cancers. Oncogene 26(29): 4284-4294.
36. Yoshioka H, Greenwel P, Inoguchi K, Truter S, Inagaki Y, Ninomiya Y, Ramirez F (1995) Structural and functional analysis of the promoter of the human 1(XI) collagen gene. J Biol Chem 270(1): 418-424.
37. Zhao Y, Zhou T, Li A, Yao H, He F, Wang L, Si J (2009) A potential role of collagens expression in distinguishing between premalignant and malignant lesions in stomach. Anat Rec(Hoboken) 292(5): 692-700.